Amalgamated Bank Avidity Biosciences, Inc. Transaction History
Amalgamated Bank
- $12.2 Billion
- Q4 2024
A detailed history of Amalgamated Bank transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 3,497 shares of RNA stock, worth $99,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,497
Previous 3,497
-0.0%
Holding current value
$99,734
Previous $161,000
36.65%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RNA
# of Institutions
259Shares Held
100MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$315 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$269 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$246 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$226 Million3.76% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.5MShares$214 Million3.18% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.49B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...